aTYR PHARMA INC
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
Index to Exhibits
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Exhibit Title | Form | File No. | Exhibit | Filing Date |
| 3.1 | Restated Certificate of Incorporation of the Registrant | 10-Q | 001-37378 | 3.1 | November 14, 2022 |
| 3.2 | Certificate of Amendment to Restated Certificate of Incorporation of the Registrant | 8-K | 001-37378 | 3.1 | June 28, 2019 |
| 3.3 | Certificate of Amendment to Restated Certificate of Incorporation of the Registrant | 10-Q | 001-37378 | 3.3 | May 12, 2020 |
| 3.4 | Certificate of Amendment to Restated Certificate of Incorporation of the Registrant | 8-K | 001-37378 | 3.1 | May 4, 2021 |
| 3.5 | Certificate of Amendment to Restated Certificate of Incorporation of the Registrant | 8-K | 001-37378 | 3.1 | April 29, 2022 |
| 3.6 | Certificate of Amendment to Restated Certificate of Incorporation of the Registrant | 8-K | 001-37378 | 3.1 | May 19, 2023 |
| 3.7 | Amended and Restated Bylaws of the Registrant | 10-Q | 333-203272 | 3.6 | November 14, 2022 |
| 4.1 | Specimen Common Stock Certificate | S-1/A | 333-203272 | 4.1 | April 27, 2015 |
| 10.1* | 2015 Stock Option Plan and Incentive Plan, as amended | 8-K | 001-37378 | 10.1 | May 6, 2025 |
| 10.2* | 2022 Inducement Plan, as amended | — | — | — | Filed herewith |
| 31.1 | Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | — | — | — | Filed herewith |
| 31.2 | Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | — | — | — | Filed herewith |
| 32.1# | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | — | — | — | Furnished herewith |
| 32.2# | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | — | — | — | Furnished herewith |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document | — | — | — | Filed herewith |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Document | — | — | — | Filed herewith |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | — | — | — | Filed herewith |
*Indicates a management contract or compensatory plan, contract or arrangement.
The information in Exhibits 32.1 and 32.2 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.